NO2009012I1 - Humanisert anti-humant IL-6 reseptor monoklonalt antistoff - Google Patents

Humanisert anti-humant IL-6 reseptor monoklonalt antistoff

Info

Publication number
NO2009012I1
NO2009012I1 NO2009012C NO2009012C NO2009012I1 NO 2009012 I1 NO2009012 I1 NO 2009012I1 NO 2009012 C NO2009012 C NO 2009012C NO 2009012 C NO2009012 C NO 2009012C NO 2009012 I1 NO2009012 I1 NO 2009012I1
Authority
NO
Norway
Prior art keywords
human
monoclonal antibody
humanized anti
receptor monoclonal
fish meat
Prior art date
Application number
NO2009012C
Other languages
English (en)
Original Assignee
Chugai Seiyaku Kk 5 1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Seiyaku Kk 5 1 filed Critical Chugai Seiyaku Kk 5 1
Publication of NO2009012I1 publication Critical patent/NO2009012I1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/40—Nucleotides, nucleosides, bases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO2009012C 1998-06-01 2009-05-28 Humanisert anti-humant IL-6 reseptor monoklonalt antistoff NO2009012I1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15095798 1998-06-01
PCT/JP1999/002904 WO1999063058A1 (fr) 1998-06-01 1999-06-01 Milieu de culture de cellules animales et procede de production de proteines en utilisant ce milieu

Publications (1)

Publication Number Publication Date
NO2009012I1 true NO2009012I1 (no) 2009-06-15

Family

ID=15508136

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20006096A NO326180B1 (no) 1998-06-01 2000-11-30 Medium for dyrking av dyreceller og fremgangsmate for fremstilling av protein ved anvendelse av de samme
NO2009012C NO2009012I1 (no) 1998-06-01 2009-05-28 Humanisert anti-humant IL-6 reseptor monoklonalt antistoff

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20006096A NO326180B1 (no) 1998-06-01 2000-11-30 Medium for dyrking av dyreceller og fremgangsmate for fremstilling av protein ved anvendelse av de samme

Country Status (16)

Country Link
US (2) US6537782B1 (no)
EP (1) EP1085083B1 (no)
JP (1) JP3510858B2 (no)
KR (1) KR100430447B1 (no)
CN (1) CN1187441C (no)
AT (1) ATE361360T1 (no)
AU (1) AU744715B2 (no)
CA (1) CA2333966C (no)
DE (1) DE69935978T2 (no)
DK (1) DK1085083T3 (no)
ES (1) ES2285840T3 (no)
HK (1) HK1037678A1 (no)
IL (1) IL139974A (no)
NO (2) NO326180B1 (no)
RU (2) RU2214455C2 (no)
WO (1) WO1999063058A1 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2312184T3 (es) 1997-03-21 2009-02-16 Chugai Seiyaku Kabushiki Kaisha Agentes preventivos terapeuticos para el tratamiento de esclerosis multiple, que contienen anticuerpos anti-receptores de il-6 antagonistas.
CA2395271A1 (en) * 1999-12-28 2001-07-05 Isotis N.V. Cell culture medium containing growth factors and l-glutamine
UA80091C2 (en) 2001-04-02 2007-08-27 Chugai Pharmaceutical Co Ltd Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
DE10124820A1 (de) 2001-05-21 2002-12-05 Heinrich Wieland Zusammensetzung und Verwendung von Substanzen zur Stabilisierung von schwefelhaltigen Aminosäuren im Blut
EP2311489A3 (en) 2002-02-14 2013-08-21 Chugai Seiyaku Kabushiki Kaisha Formulation of antibody-containing solutions comprising a sugar as a stabilizer
GB2401040A (en) 2003-04-28 2004-11-03 Chugai Pharmaceutical Co Ltd Method for treating interleukin-6 related diseases
WO2005090405A1 (ja) 2004-03-24 2005-09-29 Chugai Seiyaku Kabushiki Kaisha インターロイキン－６受容体に対するヒト型化抗体のサブタイプ
US20060094104A1 (en) * 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
KR100679112B1 (ko) * 2004-11-17 2007-02-07 삼성정밀화학 주식회사 동물세포 배양방법
EP1835022B1 (en) * 2005-01-05 2015-02-11 Chugai Seiyaku Kabushiki Kaisha Cell culture method and utilization of the same
WO2007070315A2 (en) 2005-12-08 2007-06-21 Amgen Inc. Improved production of glycoproteins using manganese
ES2474573T3 (es) * 2006-01-04 2014-07-09 Baxter International Inc Medio de cultivo celular sin oligop�ptidos
PE20091174A1 (es) * 2007-12-27 2009-08-03 Chugai Pharmaceutical Co Ltd Formulacion liquida con contenido de alta concentracion de anticuerpo
JP5711751B2 (ja) 2009-10-26 2015-05-07 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ グリコシル化された免疫グロブリンの調製方法
MD191Z5 (ro) * 2010-01-21 2010-11-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Mediu nutritiv pentru cultivarea celulelor de origine animală
MX2013005024A (es) 2010-11-08 2013-11-21 Chugai Pharmaceutical Co Ltd Anticuerpo anti-il-6 receptor administrado subcutaneamente.
CA2913687C (en) 2013-07-04 2022-12-13 F. Hoffmann-La Roche Ag Interference-suppressed immunoassay to detect anti-drug antibodies in serum samples
CA2928726A1 (en) 2013-10-30 2015-05-07 The Curators Of The University Of Missouri Method for scalable skeletal muscle lineage specification and cultivation
KR20180009760A (ko) 2015-05-27 2018-01-29 아스테라스 세이야쿠 가부시키가이샤 핵산 함유 배지를 이용한 세포 배양 방법
WO2017147169A1 (en) 2016-02-22 2017-08-31 Ohio State Innovation Foundation Chemoprevention using controlled-release formulations of anti-interleukin 6 agents, synthetic vitamin a analogues or metabolites, and estradiol metabolites
WO2018170405A1 (en) 2017-03-17 2018-09-20 Ohio State Innovation Foundation Nanoparticles for delivery of chemopreventive agents
US11976302B2 (en) 2017-05-06 2024-05-07 Upside Foods, Inc. Compositions and methods for increasing the culture density of a cellular biomass within a cultivation infrastructure
WO2019014652A1 (en) 2017-07-13 2019-01-17 Memphis Meats, Inc. COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF CELL CULTURES USED IN FOOD PRODUCTION
JP2022527972A (ja) 2019-04-02 2022-06-07 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 前悪性病変を有する患者において癌を予測及び予防する方法
WO2022137357A1 (ja) 2020-12-22 2022-06-30 株式会社マルハチ村松 ペプチド、細胞増殖促進剤、タンパク質産生促進剤、培地、該ペプチドを用いた細胞増殖方法、及び、該ペプチドを用いたタンパク質産生方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS509877B2 (no) * 1972-09-13 1975-04-16
US3962425A (en) * 1972-09-21 1976-06-08 Weyerhaeuser Company Ruminant repellent from enzymatically putrefied lipoidal material
JPS5336033B2 (no) * 1972-12-11 1978-09-30
JPH01148181A (ja) * 1987-12-07 1989-06-09 Jgc Corp グルタチオンの菌体内蓄積法
JPH0239882A (ja) * 1988-07-29 1990-02-08 Japan Synthetic Rubber Co Ltd 動物細胞培養用培地
JPH0638704A (ja) * 1991-06-19 1994-02-15 Morinaga Milk Ind Co Ltd 発酵調味料及びその製造法
US5426045A (en) 1993-12-16 1995-06-20 Sea Run Holdings, Inc. Method for culturing mammalian cells in a medium containing fish serum
WO1995023212A1 (en) 1994-02-23 1995-08-31 Sea Run Holdings, Inc. Method for culturing mammalian cells and insect cells in a medium containing fish serum
CN1157694A (zh) 1996-10-15 1997-08-27 玉环县海天营养源有限公司 一种液化鱼蛋白粉的制作方法

Also Published As

Publication number Publication date
ES2285840T3 (es) 2007-11-16
NO20006096L (no) 2001-02-01
DE69935978T2 (de) 2008-01-17
CN1309698A (zh) 2001-08-22
AU3958499A (en) 1999-12-20
US6537782B1 (en) 2003-03-25
EP1085083B1 (en) 2007-05-02
RU2333242C2 (ru) 2008-09-10
CN1187441C (zh) 2005-02-02
CA2333966C (en) 2006-07-25
WO1999063058A1 (fr) 1999-12-09
US6962812B2 (en) 2005-11-08
DK1085083T3 (da) 2007-06-18
HK1037678A1 (en) 2002-02-15
AU744715B2 (en) 2002-02-28
KR20010071359A (ko) 2001-07-28
KR100430447B1 (ko) 2004-05-10
CA2333966A1 (en) 1999-12-09
US20030096372A1 (en) 2003-05-22
ATE361360T1 (de) 2007-05-15
NO20006096D0 (no) 2000-11-30
EP1085083A1 (en) 2001-03-21
IL139974A0 (en) 2002-02-10
AU744715C (en) 1999-12-20
DE69935978D1 (de) 2007-06-14
NO326180B1 (no) 2008-10-13
IL139974A (en) 2005-09-25
JP3510858B2 (ja) 2004-03-29
EP1085083A4 (en) 2002-11-27
RU2214455C2 (ru) 2003-10-20

Similar Documents

Publication Publication Date Title
NO2009012I1 (no) Humanisert anti-humant IL-6 reseptor monoklonalt antistoff
DK0854917T3 (da) Transgene ikke-humane dyr, som kan producere heterologe antistoffer
DE3382190D1 (de) Immunogener protein- oder peptidkomplex, verfahren zur herstellung dieses komplexes und seine verwendung als immunstimulans und als impfstoff.
AU2097692A (en) Method for the production of monoclonal antibodies utilizing a germfree animal
ATE81153T1 (de) Expressionssystem zur herstellung von chimaeren monoklonalen antikoerpern.
WO1989003846A3 (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
PT2374872E (pt) Método para aumentar a expressão de altos rendimentos de proteínas de fusão ativas de um membro da família de recetor tnf, e sua purificação
NO912442D0 (no) Kunstig agn for fisk, o.l.
DE3684211D1 (no)
DE69828154D1 (de) Anti-alphavbeta3 humanizierte monoklonale antikörper
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
ATE330003T1 (de) Rekombinanter stabiler zellklon, seine herstellung und verwendung
ES2176224T3 (es) Proceso para la produccion de proteina.
NO913078L (no) Oekt proteinproduksjon i dyr.
ES2061655T3 (es) Un procedimiento para cultivar un hibridoma humano/humano productor de anticuerpos monoclonales humanos.
DE3683178D1 (de) Methode zur herstellung monoklonaler antikoerper gegen plasminogenaktivatorfaktor.
DK0839208T3 (da) Fremgangsmåde til fremme af enzymdiversitet
DE3881101D1 (de) Monoklonal-antikoerper und methode fuer die bereitung von hybridoma, produzierend diese antikoerper.
AU1621900A (en) Transgenic animals as urinary bioreactors for the production of protein in the urine, recombinant dna construct for kidney-specific expression, and method of using same
ATE407555T1 (de) Efficienter kerntransfer mit primordialen keimzellen
SE8500864D0 (sv) Sett och anordning for odling av fisk, skaldjur och dylikt
AU4775899A (en) Human monoclonal antibodies against the tumor antigen uk114 and lymphocyte cellsand hybridomas for their production
KR960029455A (ko) 인터류킨-6 의존성 성장반응을 나타내는 하이브리도마 세포주 및 이를 이용한 인터류킨-6의 활성도 측정방법
DE58904518D1 (de) Verfahren zur bildlichen darstellung von tumoren unter verwendung von monoklonalen antikoerpern.
BR1100555B1 (pt) anticorpos monoclonais humanizados.

Legal Events

Date Code Title Description
MK1K Patent expired